Abstract A considerable proportion of patients with non small cell lung cancer (NSCLC) require postoperative adjuvant therapy, postoperative radiotherapy is an important part of the treatment, this article review the role and value of postoperative radiotherapy for NSCLC patients in recent years.
Zhang Rui,Qiao Xueying. Research status of postoperative radiotherapy for non-small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2016, 25(1): 81-84.
Zhang Rui,Qiao Xueying. Research status of postoperative radiotherapy for non-small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2016, 25(1): 81-84.
[1]Parkin DM,Bray F,Ferlay J,et al. Estimating the world cancer burden:Globocan 2000[J].Int J Cancer,2001,94(2):153-156.DOI:10.1002/ijc.1440. [2]Lally BE,Zelterman D,Colasanto JM,et al. Postoperative radiotherapy for stage Ⅱ or Ⅲ non-small-cell lung cancer using the surveillance,epidemiology,and end results database[J].J Clin Oncol,2006,24(19):2998-3006.DOI:10.1200/JCO.2005.04.6110. [3]PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer[J].Cochrane Database Syst Rev,2005,(2):CD002142.DOI:10.1002/14651858.CD002142.pub2.